Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Baxter may be set to offer attractive returns

Baxter may be set to offer attractive returns

4th March 2009

Baxter may in a position to offer an attractive return to investors this year, it has been suggested.

The company’s earnings growth, margin expansion and continuing share buybacks could all contribute to a strong performance in 2009, explained Barron’s.

On Friday February 27th, the medical products manufacturer’s shares closed at $50.91 (36.31 pounds), “despite another spate of selling in the market, as investors clung to the oasis of strength”, noted the weekly financial newspaper.

It stated this figure could well increase to $65 by the end of the year.

Established over 70 years ago, Baxter operates in over 110 countries worldwide.

It has been involved in many developments in the past including kidney dialysis, heart valve replacement, blood component therapy and intravenous medicine.

The company supplies thousands of medical products and service to nearly every UK hospital and over 1,350 people are employed in this country.

Around 700 staff work at its purpose designed manufacturing facility in Thetford, Norfolk which produces intravenous fluids and urological solutions.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.